Skip to main content
Erschienen in: Netherlands Heart Journal 7-8/2015

Open Access 01.07.2015 | Letter to the Editor

Reply to the letter from Kumar et al.: Maastricht experience with the second-generation endoscopic laser balloon ablation system for the atrial fibrillation

verfasst von: P. Gal, A. Elvan

Erschienen in: Netherlands Heart Journal | Ausgabe 7-8/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
The data reported in our manuscript [1] on the results on the endoscopically assisted system (EAS) in the ablation of atrial fibrillation (AF) are remarkably similar to the data reported by Kumar et al. [2] and in the current literature. Procedure duration is around 180 min, with a fluoroscopy time of around 30 min, although there appears to be a significant learning curve [3]. Furthermore, the EAS features a favourable safety profile, which was also observed in the analysis by Kumar.
There appears to be a difference in success after about 18 months follow-up between the two papers, namely 58 % in our study population, and 81 % in the population studied by Kumar. However, the difference is not statistically significant (chi square, p  = 0.074), which is probably caused by the limited sample size in both our study group (n  = 50) and Kumar’s (n  = 24). Moreover, there appear to be more patients in persistent AF in our analysis compared with Kumar’s (18 vs. 10 %) [4]. Of note, the success rate in our study is in line with previously published larger studies. Dukkipati et al. reported a 58.5 % success rate in 200 patients after a single EAS ablation [5].
At Heart Rhythm 2014, the results of the ADVICE (adenosine following pulmonary vein isolation to target dormant conduction elimination) trial were presented. This study showed that, in case of dormant conduction during adenosine administration, additional ablations targeting the ablation gaps resulted in an increased arrhythmia-free survival post-ablation. Although not yet widely applied, adenosine testing after pulmonary vein isolation to check for dormant conduction has already been demonstrated to result in higher ablation success rates, and Kumar et al. [4] should be credited for their excellent work in this field.
More recently, we reported the impact of pulmonary vein orientation on EAS ablation outcome [6]. Interestingly, arrhythmia-free survival varied between 21 and 88 % depending on left upper Pulmonary vein (PV) orientation. Furthermore, arrhythmia-free survival varied between 21 and 86 % depending on left lower PV orientation and arrhythmia-free survival varied between 29 and 88 % depending on right lower PV orientation. However, no association was found between right upper PV orientation and AF-free survival after EAS PV isolation.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Gal P, Smit JJ, Adiyaman A, Ramdat Misier AR, Delnoy PP, Elvan A. First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation. Neth Heart J. 2015;23(2):96–9.PubMedCentralPubMedCrossRef Gal P, Smit JJ, Adiyaman A, Ramdat Misier AR, Delnoy PP, Elvan A. First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation. Neth Heart J. 2015;23(2):96–9.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Kumar N, Abbas MM, Ter Bekke RMA, et al. Maastricht experience with the second generation endoscopic laser balloon ablation system for the atrial fibrillation treatment. Neth Heart J. 2015;22. DOI: 10.1007/s12471-015-0703-8. Kumar N, Abbas MM, Ter Bekke RMA, et al. Maastricht experience with the second generation endoscopic laser balloon ablation system for the atrial fibrillation treatment. Neth Heart J. 2015;22. DOI: 10.1007/s12471-015-0703-8.
3.
Zurück zum Zitat Perrotta L, Bordignon S, Dugo D, Furnkranz A, Chun KJ, Schmidt B. How to learn pulmonary vein isolation with a novel ablation device: learning curve effects using the endoscopic ablation system. J Cardiovasc Electrophysiol. 2014;25(12):1293–8.PubMed Perrotta L, Bordignon S, Dugo D, Furnkranz A, Chun KJ, Schmidt B. How to learn pulmonary vein isolation with a novel ablation device: learning curve effects using the endoscopic ablation system. J Cardiovasc Electrophysiol. 2014;25(12):1293–8.PubMed
4.
Zurück zum Zitat Kumar N, Blaauw Y, Timmermans C, Pison L, Vernooy K, Crijns H. Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. J Interv Card Electrophysiol. 2014;41(1):91–7.PubMedCrossRef Kumar N, Blaauw Y, Timmermans C, Pison L, Vernooy K, Crijns H. Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. J Interv Card Electrophysiol. 2014;41(1):91–7.PubMedCrossRef
5.
Zurück zum Zitat Dukkipati SR, Kuck KH, Neuzil P, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6(3):467–72.PubMedCrossRef Dukkipati SR, Kuck KH, Neuzil P, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6(3):467–72.PubMedCrossRef
6.
Zurück zum Zitat Gal P, Ooms JF, Ottervanger JP, et al. Association between pulmonary vein orientation and atrial fibrillation-free survival in patients undergoing endoscopic laser balloon ablation. Eur Heart J Cardiovasc Imaging. 2015. doi:10.1093/ehjci/jeu321. Gal P, Ooms JF, Ottervanger JP, et al. Association between pulmonary vein orientation and atrial fibrillation-free survival in patients undergoing endoscopic laser balloon ablation. Eur Heart J Cardiovasc Imaging. 2015. doi:10.1093/ehjci/jeu321.
Metadaten
Titel
Reply to the letter from Kumar et al.: Maastricht experience with the second-generation endoscopic laser balloon ablation system for the atrial fibrillation
verfasst von
P. Gal
A. Elvan
Publikationsdatum
01.07.2015
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 7-8/2015
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-015-0726-1

Weitere Artikel der Ausgabe 7-8/2015

Netherlands Heart Journal 7-8/2015 Zur Ausgabe

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern. Das lassen retrospektive Daten vermuten.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.